
Burford Capital Limited BUR
$ 3.24
-6.36%
Burford Capital Limited EV/EBITDA Ratio | BUR
Annual EV/EBITDA Ratio Burford Capital Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.7 | 14.5 | 6.54 | 18.8 | 52.5 | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.5 | 6.54 | 23.4 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
PMV Pharmaceuticals
PMVP
|
-0.691 | $ 0.87 | -33.79 % | $ 45.7 M | ||
|
United Therapeutics Corporation
UTHR
|
14.4 | $ 553.08 | -1.08 % | $ 24.5 B | ||
|
Olema Pharmaceuticals
OLMA
|
-8.14 | $ 7.0 | -2.1 % | $ 609 M | ||
|
Kymera Therapeutics
KYMR
|
-22.7 | $ 115.19 | -3.52 % | $ 9.73 B | ||
|
Oragenics
OGEN
|
0.0948 | $ 0.16 | -6.16 % | $ 345 K | ||
|
Ovid Therapeutics
OVID
|
-7.27 | $ 2.2 | -5.98 % | $ 286 M | ||
|
Passage Bio
PASG
|
-1.89 | $ 3.94 | 9.14 % | $ 12.6 M | ||
|
Vaxcyte
PCVX
|
-9.39 | $ 55.37 | -5.12 % | $ 7.54 B | ||
|
Relay Therapeutics
RLAY
|
-1.72 | $ 16.11 | 1.26 % | $ 2.76 B | ||
|
Precigen
PGEN
|
-10 | $ 4.21 | 1.08 % | $ 1.32 B | ||
|
Avidity Biosciences
RNA
|
-13.4 | $ 6.94 | -0.57 % | $ 956 M | ||
|
Phio Pharmaceuticals Corp.
PHIO
|
1.37 | $ 0.66 | -7.55 % | $ 3.95 M | ||
|
Praxis Precision Medicines
PRAX
|
-21.5 | $ 300.01 | -3.5 % | $ 6.75 B | ||
|
Prelude Therapeutics Incorporated
PRLD
|
-3.06 | $ 3.22 | -1.08 % | $ 248 M | ||
|
ProQR Therapeutics N.V.
PRQR
|
-3.07 | $ 1.02 | -2.38 % | $ 107 M | ||
|
Ocular Therapeutix
OCUL
|
-4.23 | $ 5.57 | -5.03 % | $ 1.04 B | ||
|
Sana Biotechnology
SANA
|
-4.97 | $ 1.58 | -9.2 % | $ 400 M | ||
|
Outlook Therapeutics
OTLK
|
-1.56 | $ 0.39 | -2.79 % | $ 13.6 M | ||
|
uniQure N.V.
QURE
|
-6.87 | $ 19.32 | -4.5 % | $ 1.11 B | ||
|
Ultragenyx Pharmaceutical
RARE
|
-6.39 | $ 16.46 | -4.41 % | $ 1.62 B | ||
|
Rafael Holdings
RFL
|
-1.45 | $ 0.94 | 5.89 % | $ 48.3 M | ||
|
REGENXBIO
RGNX
|
-5.22 | $ 7.16 | -0.35 % | $ 369 M | ||
|
Rigel Pharmaceuticals
RIGL
|
5.31 | $ 40.05 | -2.78 % | $ 720 M | ||
|
Celsion Corporation
CLSN
|
0.248 | - | -6.63 % | $ 13.9 M | ||
|
I-Mab
IMAB
|
-37.7 | - | - | $ 866 M | ||
|
Tenax Therapeutics
TENX
|
-8.49 | $ 1.27 | -8.27 % | $ 49.8 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
29 | $ 514.68 | -1.15 % | $ 132 B | ||
|
Genfit SA
GNFT
|
50.9 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-12.1 | - | -13.47 % | $ 169 M | ||
|
SELLAS Life Sciences Group
SLS
|
-17.8 | $ 13.67 | -8.01 % | $ 1.49 B | ||
|
CureVac N.V.
CVAC
|
-2.11 | - | - | $ 867 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
-513 | - | - | $ 4.9 B | ||
|
Rezolute
RZLT
|
-4.95 | $ 3.92 | -6.69 % | $ 407 M | ||
|
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | ||
|
Tiziana Life Sciences PLC
TLSA
|
-6.58 | $ 0.63 | -7.05 % | $ 67.2 M | ||
|
MorphoSys AG
MOR
|
-9.67 | - | 2.43 % | $ 254 M | ||
|
Affimed N.V.
AFMD
|
0.361 | - | -34.95 % | $ 21.5 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-2.15 | - | -1.58 % | $ 28.1 M | ||
|
Celyad Oncology SA
CYAD
|
0.0447 | - | - | $ 12.5 M | ||
|
Seer
SEER
|
0.144 | $ 1.34 | -3.25 % | $ 74.5 M | ||
|
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B | ||
|
Summit Therapeutics
SMMT
|
81.3 K | $ 9.94 | -6.01 % | $ 7.43 B | ||
|
Shattuck Labs
STTK
|
-6.35 | $ 4.49 | -1.43 % | $ 312 M | ||
|
Silence Therapeutics plc
SLN
|
-48.1 | $ 19.81 | 0.08 % | $ 2.81 B | ||
|
Soligenix
SNGX
|
-0.18 | $ 0.22 | -8.25 % | $ 1.14 M | ||
|
Sanofi
SNY
|
8.13 | $ 46.51 | 0.97 % | $ 56.8 B | ||
|
Spruce Biosciences
SPRB
|
-0.252 | $ 38.02 | -6.11 % | $ 29.1 M |